| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurology (Drs. Schwid, Goodman, Mattson, Mihai, Donohoe, Petrie, Scheid, Dudman, and McDermott), Microbiology and Immunology(Dr. Mattson), and Biostatistics (Dr. McDermott), University of Rochester Medical Center, Rochester, NY.
Address correspondence and reprint requests to Dr. Steven R. Schwid, 601 Elmwood Avenue, Box 605, Rochester, NY 14642.
The objective of this study was to examine the relationships between continuous measures of ambulatory impairment in MS patients and their ordinal counterparts. Much of the disability caused by MS is due to ambulatory impairment. The Expanded Disability Severity Scale (EDSS) and the Ambulation Index (AI) are ordinal measures of MS severity based largely on the maximal distance subjects can walk (Dmax) and the time to walk 8 m (T8), respectively. At EDSS levels 6.0 to 7.0 and AI levels 3 to 6, scores are defined more by the use of ambulatory aids, rather than by Dmax or T8. We determined Dmax (up to 500 m), T8, the EDSS score, and the AI in 237 ambulatory MS patients. The maximal distance subjects could walk and T8 were strongly related to their ordinal counterparts (Spearman r = 0.65 and 0.91, respectively), but the continuous measures showed considerable variability within EDSS and AI levels that the ordinal scales did not reflect. Most of the variability occurred at EDSS levels 6.0 to 7.0 and AI levels 3 to 6. Because the use of an aid did not clearly predict Dmax or T8, many patients in these ranges had better ambulatory function based on the continuous measures than those with less disability according to the ordinal scales. We found that Dmax and T8 provide more precise information about ambulatory impairment in MS than do the EDSS and AI, allowing better discrimination of differences between patients and potentially greater sensitivity to detect therapeutic effects in clinical trials.
Received February 13, 1997. Accepted in final form April 25, 1997.
This article has been cited by other articles:
|
|
 |
|
  M. R. Benjamins and M. Finlayson Using Religious Services to Improve Health: Findings From a Sample of Middle-Aged and Older Adults With Multiple Sclerosis J Aging Health, June 1, 2007; 19(3): 537 - 553. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Rampello, M. Franceschini, M. Piepoli, R. Antenucci, G. Lenti, D. Olivieri, and A. Chetta Effect of Aerobic Training on Walking Capacity and Maximal Exercise Tolerance in Patients With Multiple Sclerosis: A Randomized Crossover Controlled Study Physical Therapy, May 1, 2007; 87(5): 545 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.D. Goodman, J.A. Cohen, A. Cross, T. Vollmer, M. Rizzo, R. Cohen, L. Marinucci, and A.R. Blight Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study Multiple Sclerosis, April 1, 2007; 13(3): 357 - 368. [Abstract] [PDF]
|
|
|
|
|
|
J J Kragt, F A. van der Linden, J M Nielsen, B M. Uitdehaag, and C H Polman Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis Multiple Sclerosis, September 1, 2006; 12(5): 594 - 598. [Abstract] [PDF]
|
|
|
|
|
|
L K Storr, P S Sorensen, and M Ravnborg The efficacy of multidisciplinary rehabilitation in stable multiple sclerosis patients Multiple Sclerosis, April 1, 2006; 12(2): 235 - 242. [Abstract] [PDF]
|
|
|
|
 |
|
 K. M. Zackowski, P. Dubey, G. V. Raymond, S. Mori, A. J. Bastian, and H. W. Moser Sensorimotor Function and Axonal Integrity in Adrenomyeloneuropathy Arch Neurol, January 1, 2006; 63(1): 74 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Romberg, A. Virtanen, J. Ruutiainen, S. Aunola, S.-L. Karppi, M. Vaara, J. Surakka, T. Pohjolainen, and A. Seppanen Effects of a 6-month exercise program on patients with multiple sclerosis: A randomized study Neurology, December 14, 2004; 63(11): 2034 - 2038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O.R. Pearson, M.E. Busse, R.W.M. van Deursen, and C.M. Wiles Quantification of walking mobility in neurological disorders QJM, August 1, 2004; 97(8): 463 - 475. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Surakka, A. Romberg, J. Ruutiainen, S. Aunola, A. Virtanen, S.-L. Karppi, and K. Maentaka Effects of aerobic and strength exercise on motor fatigue in men and women with multiple sclerosis: a randomized controlled trial Clinical Rehabilitation, July 1, 2004; 18(7): 737 - 746. [Abstract] [PDF]
|
|
|
|
|
|
C Vaney, S Vaney, and D T Wade SaGA S, the Short and Graphic A bility Score: an alternative scoring method for the motor components of the Multiple Sclerosis Functional C omposite Multiple Sclerosis, April 1, 2004; 10(2): 231 - 242. [Abstract] [PDF]
|
|
|
|
|
|
T. Giantomaso, L. Makowsky, N. L Ashworth, and R. Sankaran The validity of patient and physician estimates of walking distance Clinical Rehabilitation, April 1, 2003; 17(4): 394 - 401. [Abstract] [PDF]
|
|
|
|
|
|
R A Rudick, G Cutter, and S Reingold The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis trials Multiple Sclerosis, October 1, 2002; 8(5): 359 - 365. [Abstract] [PDF]
|
|
|
|
|
|
E M Cheng, R D Hays, L W Myers, G W Ellison, M Beckstrand, and B G Vickrey Factors related to agreement between self-reported and conventional Expanded Disability Status Scale (EDSS) scores Multiple Sclerosis, December 1, 2001; 7(6): 405 - 410. [Abstract] [PDF]
|
|
|
|
|
|
H Albrecht, C Wotzel, L P Erasmus, M Kleinpeter, N Konig, and W Pollmann Day-to-day variability of maximum walking distance in MS patients can mislead to relevant changes in the Expanded Disability Status Scale (EDSS): average walking speed is a more constant parameter Multiple Sclerosis, April 1, 2001; 7(2): 105 - 109. [Abstract] [PDF]
|
|
|
|
|
|
S. R. Schwid, A. D. Goodman, B. R. Apatoff, P. K. Coyle, L. D. Jacobs, L. B. Krupp, A. E. Miller, K. E. Wende, C. M. Brownscheidle, and a. t. New York State Multiple Sclerosis Consortium* Are quantitative functional measures more sensitive to worsening MS than traditional measures? Neurology, December 26, 2000; 55(12): 1901 - 1903. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Kaufman, D Moyer, and J Norton The significant change for the Timed 25-Foot Walk in the Multiple Sclerosis Functional Composite Multiple Sclerosis, August 1, 2000; 6(4): 286 - 290. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Liu and L. D Blumhardt Randomised, double blind, placebo controlled study of interferon beta -1a in relapsing-remitting multiple sclerosis analysed by area under disability/time curves J. Neurol. Neurosurg. Psychiatry, October 1, 1999; 67(4): 451 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Schwid, C. A. Thornton, S. Pandya, K. L. Manzur, M. Sanjak, M. D. Petrie, M. P. McDermott, and A. D. Goodman Quantitative assessment of motor fatigue and strength in MS Neurology, September 1, 1999; 53(4): 743 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J S Fischer, R A Rudick, G R Cutter, S C Reingold, and National MS Society Clinical Outcomes Assessment T The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment Multiple Sclerosis, August 1, 1999; 5(4): 244 - 250. [Abstract] [PDF]
|
|
|
|
 |
|
 G. R. Cutter, M. L. Baier, R. A. Rudick, D. L. Cookfair, J. S. Fischer, J. Petkau, K. Syndulko, B. G. Weinshenker, J. P. Antel, C. Confavreux, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure Brain, May 1, 1999; 122(5): 871 - 882. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
